Novo Nordisk announces collaboration with WeightWatchers to offer patients living with obesity access to FDA-approved Wegovy ...

Legal wins build on 111 lawsuits filed by Novo Nordisk across 32 states against entities unlawfully marketing and selling compounded "semaglutide" drugs, ... FDA-approved Wegovy ...

Drugmaker Novo Nordisk said it is halting its agreement with telehealth company Hims & Hers after less than two months, ...

Novo Nordisk says oral version of Wegovy accepted for FDA review. May 02, 2025 2:50 PM ET ... Subject to FDA approval of the company's new ... marking the first late-stage trial win for the GLP-1 ...

When the FDA declared the shortage resolved for semaglutide, the main pharmaceutical ingredient in Wegovy and Ozempic, the agency gave 503B facilities until May 22 to stop making compounded versions.

Regeneron said on Monday its experimental drug helped patients preserve up to 51% of lean mass and lose more fat when used in combination with Novo Nordisk's popular obesity drug Wegovy in a mid-stage ...

CVS Health on Thursday said it will significantly expand access to the blockbuster weight loss drug Wegovy for patients covered by its pharmacy benefit manager, Caremark. Starting July 1, Caremark ...

Legal wins build on 111 lawsuits filed by Novo Nordisk across 32 states against entities unlawfully marketing and selling compounded "semaglutide" drugs, ... FDA-approved Wegovy ...

Separately, any patient who does not have insurance coverage for Wegovy or another GLP-1 can still buy Novo Nordisk's drug out-of-pocket for $499 at any of CVS' 9,000 pharmacies nationwide, the ...